Correlation Between Pulmatrix and Cyteir Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pulmatrix and Cyteir Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pulmatrix and Cyteir Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pulmatrix and Cyteir Therapeutics, you can compare the effects of market volatilities on Pulmatrix and Cyteir Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pulmatrix with a short position of Cyteir Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pulmatrix and Cyteir Therapeutics.
Diversification Opportunities for Pulmatrix and Cyteir Therapeutics
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Pulmatrix and Cyteir is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Pulmatrix and Cyteir Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyteir Therapeutics and Pulmatrix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pulmatrix are associated (or correlated) with Cyteir Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyteir Therapeutics has no effect on the direction of Pulmatrix i.e., Pulmatrix and Cyteir Therapeutics go up and down completely randomly.
Pair Corralation between Pulmatrix and Cyteir Therapeutics
If you would invest 212.00 in Pulmatrix on September 18, 2024 and sell it today you would earn a total of 363.00 from holding Pulmatrix or generate 171.23% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 1.59% |
Values | Daily Returns |
Pulmatrix vs. Cyteir Therapeutics
Performance |
Timeline |
Pulmatrix |
Cyteir Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pulmatrix and Cyteir Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pulmatrix and Cyteir Therapeutics
The main advantage of trading using opposite Pulmatrix and Cyteir Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pulmatrix position performs unexpectedly, Cyteir Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyteir Therapeutics will offset losses from the drop in Cyteir Therapeutics' long position.Pulmatrix vs. Emergent Biosolutions | Pulmatrix vs. Neurocrine Biosciences | Pulmatrix vs. Teva Pharma Industries | Pulmatrix vs. Haleon plc |
Cyteir Therapeutics vs. Nuvation Bio | Cyteir Therapeutics vs. Foghorn Therapeutics | Cyteir Therapeutics vs. C4 Therapeutics | Cyteir Therapeutics vs. Prelude Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |